Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Weikert Gunnar
  2. Issuer Name and Ticker or Trading Symbol
Organic To Go Food CORP [OTGO]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
3317 THIRD AVENUE SOUTH
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2009
(Street)

SEATTLE, WA 98134
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 02/19/2009   C   132,653,061 A $ 0.075 139,795,918 I By W.Health L.P. (1) (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Convertible Promissory Notes $ 0.075 02/19/2009   C     10,000,000   (4)   (4) Common Stock 132,653,061 $ 0 0 I By W.Health L.P. (1) (2)
Convertible Promissory Notes $ 0.14 02/19/2009   P   5,000,000   02/19/2009 03/17/2010 Common Stock 35,714,286 $ 0.14 35,714,286 I By W.Health L.P. (1)
Warrants (2) (3) 02/27/2008(3)   P(2)   5,535,715 (2)     (3)   (3) Common Stock 5,535,715 (2) 5,535,715 I By W.Health L.P. (1)
Option (right to buy) $ 1.4 03/11/2009   J(5)     83,333   (6) 02/26/2018 Common Stock 83,333 $ 1.4 83,333 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Weikert Gunnar
3317 THIRD AVENUE SOUTH
SEATTLE, WA 98134
  X   X    

Signatures

 /s/ Dr. Gunnar Weikert   03/12/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Mr. Gunnar Weikert is one of the general partners and directors of Inventages Whealth Management, Inc. which is the general partner of W.Health L.P., the direct holder of the securities reported hereunder, and may be deemed to be the beneficial holder of, and to share the power to vote and dispose of, the securities owned directly by W.Health L.P.
(2) These securities held indirectly by Mr. Weikert included in this filing were erroneously omitted in a prior filing.
(3) The exercise price of the warrants range from $2.50 to $3.00 per share of Common Stock. The warrants were issued between February 27, 2008 and October 3, 2008 and expire between February 27, 2013 and October 3, 2013.
(4) The Convertible Promissory Notes were exercisable at various dates between June 17, 2008 and October 3, 2008 and their expiration date was March 17, 2010.
(5) Dr. Gunnar Weikert disclaimed ownership of the options on March 11, 2009.
(6) The options vest monthly in equal installments over a two year period beginning on February 27, 2008 and ending on February 27, 2010, with the first installment vesting on March 27, 2008.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.